申请人:Hoffmann-La Roche Inc.
公开号:US04549988A1
公开(公告)日:1985-10-29
There is presented 3H-2-benzazepines and 4,5-dihydro-3H-2-benzazepines of the formula ##STR1## wherein X is hydrogen, chloro or bromo, Y is hydrogen, fluoro or chloro with the proviso that X and Y cannot both be hydrogen and R.sub.1 is selected from the group consisting of hydrogen, bromo, chloro, iodo, a radical of the formula ##STR2## and a radical of the formula ##STR3## wherein R.sub.2 is hydrogen, phthalimido, lower alkyl, hydroxy, amino, monoalkylamino and dialkylamino and R.sub.3 is hydroxy, phthalimido or amino with the proviso that where R.sub.1 is other than hydrogen then the bonding at the 4,5-position is unsaturated, and the pharmaceutically acceptable salts thereof.
本文介绍了式子为##STR1##的3H-2-苯并氮杂环和4,5-二氢-3H-2-苯并氮杂环,其中X为氢、氯或溴,Y为氢、氟或氯,但X和Y不能同时为氢,R.sub.1选自以下组合:氢、溴、氯、碘、式子##STR2##的基团和式子##STR3##的基团,其中R.sub.2为氢、邻苯二甲酰亚胺、低碳基、羟基、氨基、单烷基氨基和双烷基氨基,R.sub.3为羟基、邻苯二甲酰亚胺或氨基,但当R.sub.1不是氢时,4,5-位置的键合是不饱和的,以及其药学上可接受的盐。